Tetra Bio-Pharma Inc. (JAM1.F)
Chart Events
Performance Outlook
| Previous Close | 0.1248 |
| Open | 0.0972 |
| Bid | 0.0899 x 4074100 |
| Ask | 0.1184 x 2558200 |
| Day's Range | 0.0972 - 0.1050 |
| 52 Week Range | 0.0902 - 0.3525 |
| Volume | |
| Avg. Volume | 6,815 |
| Market Cap | 40.882M |
| Beta (5Y Monthly) | 2.14 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0770 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
CEOs Presenting at the Emerging Growth Conference on December 8; Register Now
Niche Companies in Technology, Biotech / FinTech, BioTech, Precious Metals, Utilities, Technology, Blockchain, and more in Attendance.MIAMI, Dec. 07, 2021 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets, announces the Schedule of the 21st Emerging Growth Conference. The Emerging Growth Conference identifies companies in a wide range of growth sectors, wit
- ACCESSWIRE
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience.The SNN Network Canada Virtual Event begins on Tuesday, December 7, 2021 with the "MicroCap Investing Workshop" starting at 8:00am EST and featuring well-known financial influencers, investors, fund managers, and key opinion leaders inc
- CNW Group
Tetra Bio-Pharma Announces Up To $13.0 Million Marketed Public Offering of Units
Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that it has entered into an agreement with Research Capital Corporation and Echelon Wealth Partners Inc., acting as co-lead agents and joint bookrunners (the "Agents"), in connection with a marketed public offering of units of the Company (the "Units") for aggregate gross proceeds of up to $13,000,000 (the "Offering"), at a
